Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months.
about
Glatiramer acetate for multiple sclerosisAdherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience.The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.
P2860
Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Tolerability, adverse events a ...... ously for at least six months.
@ast
Tolerability, adverse events a ...... ously for at least six months.
@en
type
label
Tolerability, adverse events a ...... ously for at least six months.
@ast
Tolerability, adverse events a ...... ously for at least six months.
@en
prefLabel
Tolerability, adverse events a ...... ously for at least six months.
@ast
Tolerability, adverse events a ...... ously for at least six months.
@en
P2860
P1476
Tolerability, adverse events a ...... ously for at least six months.
@en
P2093
Ana Patricia Perez Fiore
P2860
P304
P356
10.1590/S0004-282X2005000500002
P577
2005-09-01T00:00:00Z